Literature DB >> 18652994

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.

Catherine G Sutcliffe1, Janneke H van Dijk, Carolyn Bolton, Deborah Persaud, William J Moss.   

Abstract

Assessment of antiretroviral treatment programmes for HIV-infected children in sub-Saharan Africa is important to enable the development of effective care and improve treatment outcomes. We review the effectiveness of paediatric antiretroviral treatment programmes in sub-Saharan Africa and discuss the implications of these findings for the care and treatment of HIV-infected children in this region. Available reports indicate that programmes in sub-Saharan Africa achieve treatment outcomes similar to those in North America and Europe. However, progress in several areas is required to improve the care of HIV-infected children in sub-Saharan Africa. The findings emphasise the need for low-cost diagnostic tests that allow for earlier identification of HIV infection in infants living in sub-Saharan Africa, improved access to antiretroviral treatment programmes, including expansion of care into rural areas, and the integration of antiretroviral treatment programmes with other health-care services, such as nutritional support.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652994     DOI: 10.1016/S1473-3099(08)70180-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  152 in total

1.  Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.

Authors:  William I Towler; Linda Barlow-Mosha; Jessica D Church; Danstan Bagenda; Patrick Ajuna; Micheal Mubiru; Philippa Musoke; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

2.  Evaluation of a high-throughput diagnostic system for detection of HIV-1 in dried blood spot samples from infants in Mozambique.

Authors:  Ilesh V Jani; Jennifer Sabatier; Adolfo Vubil; Shambavi Subbarao; Dulce Bila; Amina de Sousa; Nédio Mabunda; Albert Garcia; Beth Skaggs; Dennis Ellenberger; Artur Ramos
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

3.  Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America.

Authors:  Marco T Luque; Cathy A Jenkins; Bryan E Shepherd; Denis Padgett; Vanessa Rouzier; Regina Célia M Succi; Daisy M Machado; Catherine C McGowan; Sten H Vermund; Jorge A Pinto
Journal:  J Pediatr       Date:  2017-01-09       Impact factor: 4.406

4.  Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings.

Authors:  Tamsen Jean Rochat; Ruth Bland; Hoosen Coovadia; Alan Stein; Marie-Louise Newell
Journal:  Future Virol       Date:  2011-06       Impact factor: 1.831

5.  Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.

Authors:  Ricardo Oliveira; Margot Krauss; Suzanne Essama-Bibi; Cristina Hofer; D Robert Harris; Adriana Tiraboschi; Ricardo de Souza; Heloisa Marques; Regina Succi; Thalita Abreu; Marinella Della Negra; Rohan Hazra; Lynne M Mofenson; George K Siberry
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

6.  Cohort profile: the TREAT Asia pediatric HIV observational database.

Authors:  Azar Kariminia; Kulkanya Chokephaibulkit; Joselyn Pang; Pagakrong Lumbiganon; Rawiwan Hansudewechakul; Janaki Amin; Nagalingeswaran Kumarasamy; Thanyawee Puthanakit; Nia Kurniati; Nik Khairulddin Nik Yusoff; Vonthanak Saphonn; Siew Moy Fong; Kamarul Razali; Revathy Nallusamy; Annette H Sohn; Virat Sirisanthana
Journal:  Int J Epidemiol       Date:  2010-01-25       Impact factor: 7.196

7.  Disclosure of their HIV status to perinatally infected youth using the adapted Blasini disclosure model in Haiti and the Dominican Republic: preliminary results.

Authors:  Consuelo M Beck-Sagué; Jessy Dévieux; Maria Claudia Pinzón-Iregui; Leonel Lerebours-Nadal; Rosa Abreu-Pérez; Rachel Bertrand; Vanessa Rouzier; Stephanie Gaston; Gladys Ibanez; Mina Halpern; Jean W Pape; Patricia Dorceus; Sharice M Preston; Andrew G Dean; Stephen W Nicholas; Ileana Blasini
Journal:  AIDS       Date:  2015-06       Impact factor: 4.177

8.  The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.

Authors:  L N Barlow-Mosha; D S Bagenda; P K Mudiope; M C Mubiru; L M Butler; M G Fowler; P M Musoke
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

9.  Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya.

Authors:  Emily Koech; Chloe A Teasdale; Chunhui Wang; Ruby Fayorsey; Terezah Alwar; Irene N Mukui; Mark Hawken; Elaine J Abrams
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

10.  Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.

Authors:  Chloe A Teasdale; Elaine J Abrams; Ashraf Coovadia; Renate Strehlau; Leigh Martens; Louise Kuhn
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.